Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Vitamin C as a Modulator of the Response to Cancer Therapy.

Blaszczak W, Barczak W, Masternak J, Kopczyński P, Zhitkovich A, Rubiś B.

Molecules. 2019 Jan 28;24(3). pii: E453. doi: 10.3390/molecules24030453. Review.

2.

Fucoidan Exerts Anticancer Effects Against Head and Neck Squamous Cell Carcinoma In Vitro.

Blaszczak W, Lach MS, Barczak W, Suchorska WM.

Molecules. 2018 Dec 12;23(12). pii: E3302. doi: 10.3390/molecules23123302.

3.

hTERT promoter methylation status in peripheral blood leukocytes as a molecular marker of head and neck cancer progression.

Sobecka A, Blaszczak W, Barczak W, Golusinski P, Rubis B, Masternak MM, Suchorska WM, Golusinski W.

J Appl Genet. 2018 Nov;59(4):453-461. doi: 10.1007/s13353-018-0458-1. Epub 2018 Aug 7.

PMID:
30088231
4.

Blood Serum From Head and Neck Squamous Cell Carcinoma Patients Induces Altered MicroRNA and Target Gene Expression Profile in Treated Cells.

Allen B, Schneider A, Victoria B, Nunez Lopez YO, Muller M, Szewczyk M, Pazdrowski J, Majchrzak E, Barczak W, Golusinski W, Golusinski P, Masternak MM.

Front Oncol. 2018 Jun 11;8:217. doi: 10.3389/fonc.2018.00217. eCollection 2018.

5.

hTERT gene knockdown enhances response to radio- and chemotherapy in head and neck cancer cell lines through a DNA damage pathway modification.

Barczak W, Sobecka A, Golusinski P, Masternak MM, Rubis B, Suchorska WM, Golusinski W.

Sci Rep. 2018 Apr 13;8(1):5949. doi: 10.1038/s41598-018-24503-y.

6.

Tissue and serum microRNA profile of oral squamous cell carcinoma patients.

Schneider A, Victoria B, Lopez YN, Suchorska W, Barczak W, Sobecka A, Golusinski W, Masternak MM, Golusinski P.

Sci Rep. 2018 Jan 12;8(1):675. doi: 10.1038/s41598-017-18945-z.

7.

Association of DNA repair genes polymorphisms and mutations with increased risk of head and neck cancer: a review.

Dylawerska A, Barczak W, Wegner A, Golusinski W, Suchorska WM.

Med Oncol. 2017 Nov 15;34(12):197. doi: 10.1007/s12032-017-1057-4. Review.

8.

hTERT C250T promoter mutation and telomere length as a molecular markers of cancer progression in patients with head and neck cancer.

Barczak W, Suchorska WM, Sobecka A, Bednarowicz K, Machczynski P, Golusinski P, Rubis B, Masternak MM, Golusinski W.

Mol Med Rep. 2017 Jul;16(1):441-446. doi: 10.3892/mmr.2017.6590. Epub 2017 May 17.

PMID:
28535013
9.

Clinical value of monoclonal antibodies and tyrosine kinase inhibitors in the treatment of head and neck squamous cell carcinoma.

Blaszczak W, Barczak W, Wegner A, Golusinski W, Suchorska WM.

Med Oncol. 2017 Apr;34(4):60. doi: 10.1007/s12032-017-0918-1. Epub 2017 Mar 17. Review.

10.

RNA interference in head and neck oncology.

Sobecka A, Barczak W, Suchorska WM.

Oncol Lett. 2016 Nov;12(5):3035-3040. Epub 2016 Sep 2.

11.

The importance of stem cell engineering in head and neck oncology.

Barczak W, Golusiński P, Luczewski L, Suchorska WM, Masternak MM, Golusiński W.

Biotechnol Lett. 2016 Oct;38(10):1665-72. doi: 10.1007/s10529-016-2163-7. Epub 2016 Jun 24. Review.

12.

Telomere length assessment in leukocytes presents potential diagnostic value in patients with breast cancer.

Barczak W, Rozwadowska N, Romaniuk A, Lipińska N, Lisiak N, Grodecka-Gazdecka S, Książek K, Rubiś B.

Oncol Lett. 2016 Mar;11(3):2305-2309. Epub 2016 Feb 4.

13.

Telomere shortening in Down syndrome patients--when does it start?

Gruszecka A, Kopczyński P, Cudziło D, Lipińska N, Romaniuk A, Barczak W, Rozwadowska N, Totoń E, Rubiś B.

DNA Cell Biol. 2015 Jun;34(6):412-7. doi: 10.1089/dna.2014.2746. Epub 2015 Mar 18.

14.

Universal real-time PCR-based assay for lentiviral titration.

Barczak W, Suchorska W, Rubiś B, Kulcenty K.

Mol Biotechnol. 2015 Feb;57(2):195-200. doi: 10.1007/s12033-014-9815-4.

15.

Study of ABCB1 polymorphism frequency in breast cancer patients from Poland.

Rubiś B, Hołysz H, Barczak W, Gryczka R, Łaciński M, Jagielski P, Czernikiewicz A, Półrolniczak A, Wojewoda A, Perz K, Białek P, Morze K, Kanduła Z, Lisiak N, Mrozikiewicz PM, Grodecka-Gazdecka S, Rybczyńska M.

Pharmacol Rep. 2012;64(6):1560-6.

Supplemental Content

Loading ...
Support Center